Ryvu Therapeutics Q2 net loss 13.1 million zlotys
Ryvu Therapeutics reported a Q2 net loss of 13.1 million zlotys.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ryvu Therapeutics reported a Q2 net loss of 13.1 million zlotys.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.